Sacituzumab Govitecan Promising in Triple-Negative Breast Cancer
Response rate of 33.3 percent, median response duration of 7.7 months observed in 108 patients
Read MoreFeb 21, 2019
Response rate of 33.3 percent, median response duration of 7.7 months observed in 108 patients
Read MoreFeb 21, 2019
Primary end point occurred in lower percentage of patients in 180-day period; difference not significant
Read MoreFeb 21, 2019
Cognitive activity in midlife linked to reduced risks for total dementia, Alzheimer disease
Read MoreFeb 21, 2019
About half of those reporting dissatisfaction at preop saw clinically meaningful improvement
Read MoreFeb 21, 2019
Risk 2.7 percent in women aged 85 years and older, 23.6 percent in men aged 55 to 59 years
Read MoreFeb 21, 2019
Restoration of proprioception seen in two transradial amputees; detection of slipping in hand amputee
Read MoreFeb 21, 2019
Additional 10 primary care physicians per 100,000 population linked to reduced mortality
Read MoreFeb 21, 2019
CTE-related ptau pathology evolves according to age; CTE frequency higher in professional football players
Read MoreFeb 21, 2019
Company has faced lawsuits linking its body powders with ovarian cancer or mesothelioma
Read MoreFeb 21, 2019
Proposed rule will help consumers better understand what the sunscreens they are buying can actually do
Read MoreFeb 21, 2019
Assessments will lay groundwork for future study of the health effects of perfluoroalkyl, polyfluoroalkyl
Read MoreFeb 20, 2019
Cases of glottic carcinoma in patients aged 30 years or younger tested positive for high-risk HPV
Read MoreFeb 20, 2019
Any exposure increases spontaneous abortion risk; cardiac septal defects up for use in early pregnancy
Read MoreFeb 20, 2019
Trial unavailable at patients’ institution 55.6 percent of the time; 21.5 percent of patients ineligible
Read MoreFeb 20, 2019
Mean five-year change lower in Expanded Disability Status Scale score with early intensive treatment
Read MoreFeb 20, 2019
Cancer deaths rates decreasing faster for black men and women vs. white men and women in U.S.
Read MoreFeb 20, 2019
Reduced risk seen for total CVD, coronary heart disease incidence for men and women
Read MoreFeb 20, 2019
Television accounted for most screen time in children aged 0 to 2 and 3 to 5 years in 2014
Read MoreFeb 20, 2019
Two large trials show benefits for pembrolizumab-axitinib and avelumab-axitinib versus sunitinib
Read MoreFeb 20, 2019
Patients with lupus had fivefold greater representation of Ruminococcus gnavus
Read More